Search by Drug Name or NDC

    NDC 59651-0113-90 Febuxostat 40 mg/1 Details

    Febuxostat 40 mg/1

    Febuxostat is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Aurobindo Pharma Limited. The primary component is FEBUXOSTAT.

    Product Information

    NDC 59651-0113
    Product ID 59651-113_04f80eb2-8171-4e18-93e4-514440e84b75
    Associated GPIs
    GCN Sequence Number 064829
    GCN Sequence Number Description febuxostat TABLET 40 MG ORAL
    HIC3 C7A
    HIC3 Description HYPERURICEMIA TX - XANTHINE OXIDASE INHIBITORS
    GCN 16808
    HICL Sequence Number 036106
    HICL Sequence Number Description FEBUXOSTAT
    Brand/Generic Generic
    Proprietary Name Febuxostat
    Proprietary Name Suffix n/a
    Non-Proprietary Name Febuxostat
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 40
    Active Ingredient Units mg/1
    Substance Name FEBUXOSTAT
    Labeler Name Aurobindo Pharma Limited
    Pharmaceutical Class Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA210741
    Listing Certified Through 2024-12-31

    Package

    NDC 59651-0113-90 (59651011390)

    NDC Package Code 59651-113-90
    Billing NDC 59651011390
    Package 90 TABLET in 1 BOTTLE (59651-113-90)
    Marketing Start Date 2023-10-25
    NDC Exclude Flag N
    Pricing Information N/A